DCC-2618 1225278-16-9

PDGFRinhibitor1 is an orally active Kit(c-Kit) and PDGFRinhibitor with potential antitumor activity. It also inhibits several other kinases, including VEGFR2, TIE2, PDGFR-beta, and CSF1R, thereby inhibiting tumor cell growth.